-
Loading metrics
Open Access
Peer-reviewed
Research Article
The Antitumor Activity of the Novel Compound Jesridonin on Human Esophageal Carcinoma Cells
-
Cong Wang ,
Contributed equally to this work with: Cong Wang, Liping Jiang
Affiliations School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan, 450001, China, New Drug Research & Development Center, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan, 450001, China
⨯ -
Liping Jiang ,
Contributed equally to this work with: Cong Wang, Liping Jiang
Affiliations School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan, 450001, China, New Drug Research & Development Center, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan, 450001, China
⨯ -
Saiqi Wang,
Affiliations School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan, 450001, China, New Drug Research & Development Center, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan, 450001, China
⨯ -
Hongge Shi,
Affiliations School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan, 450001, China, New Drug Research & Development Center, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan, 450001, China
⨯ -
Junwei Wang,
Affiliations School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan, 450001, China, New Drug Research & Development Center, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan, 450001, China
⨯ -
Ran Wang,
Affiliations School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan, 450001, China, New Drug Research & Development Center, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan, 450001, China
⨯ -
Yongmei Li,
Affiliations School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan, 450001, China, New Drug Research & Development Center, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan, 450001, China
⨯ -
Yinhui Dou,
Affiliations School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan, 450001, China, New Drug Research & Development Center, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan, 450001, China
⨯ -
Ying Liu,
Affiliations School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan, 450001, China, New Drug Research & Development Center, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan, 450001, China
⨯ -
Guiqin Hou,
Affiliations School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan, 450001, China, New Drug Research & Development Center, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan, 450001, China
⨯ -
Yu Ke ,
* E-mail: liuhm@zzu.edu.cn (HML); ky@zzu.edu.cn (YK)
Affiliations School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan, 450001, China, New Drug Research & Development Center, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan, 450001, China
⨯ -
Hongmin Liu
* E-mail: liuhm@zzu.edu.cn (HML); ky@zzu.edu.cn (YK)
Affiliations School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan, 450001, China, New Drug Research & Development Center, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan, 450001, China
⨯
The Antitumor Activity of the Novel Compound Jesridonin on Human Esophageal Carcinoma Cells
- Cong Wang,
- Liping Jiang,
- Saiqi Wang,
- Hongge Shi,
- Junwei Wang,
- Ran Wang,
- Yongmei Li,
- Yinhui Dou,
- Ying Liu,
- Guiqin Hou
- Published: June 23, 2015
- https://doi.org/10.1371/journal.pone.0130284